February 10th, 2016, Vancouver, B.C. – Veritas Pharma Inc. (“VRT” or the “Company”) (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) named Whistler Medical Marijuana Corporation as its principal supplier of cannabis cultivars. Over the next 18 months, the company will purchase this material from Whistler and supply it to Cannevert Therapeutics Ltd. for preclinical and clinical testing.

Whistler Medical Marijuana Corp. is licensed by Health Canada to produce dried or fresh marijuana as well as cannabis oil. They have an expert growing team with over 20 years of experience in high-tech organic growing systems including cannabis, organic grapes & berry crops, and greenhouse production of tomatoes, cucumbers and peppers.  They use 100% certified organic crop inputs and growing methods, which make them a Certified Organic Licensed Producer.  This certification is provided by the Fraser Valley Organic Producers Association (FVOPA).

Veritas Pharma Inc. is also pleased to announce the appointment of Jesse McConnell, Peter Doig and Peter Smith to its new advisory board.

Jesse McConnell is the co-founder of Whistler Medical Marijuana Corp. and an expert in organic cannabis cultivation. He was instrumental in establishing the first federally legal, certified organic cannabis cultivation facility in the World.  Jesse has extensive knowledge of organic, scientific, technical, regulatory, and quality-related best practices governing medical cannabis and Certified Organic growing methods. Jesse holds a Master’s degree in Philosophy from the University of Victoria.

Peter Doig is a Professional Agrologist (P.Ag) with a Master’s degree in Chemical and Bio-Resource Engineering. He specializes in converting conventional agricultural systems over to certified organic practices without compromising product yield or quality. His past projects received several NRC-IRAP grants, BC Innovation Council awards, CRA’s Scientific Research and Experimental Development Tax Credits as well the National Award for Excellence in Innovation by CIPA.

Peter Smith is a lawyer with over 10 years’ experience as a CEO and/or director of TSX-V listed companies. He is the former clerk to the Supreme Court of Canada and a former attorney at Debevoise & Plimpton (NY). Most recently, he was Chairman of the Board for Less Mess Storage Inc. (TSXV-LMS), which owns and operates the largest self-storage chain in Central and Eastern Europe and was acquired and taken private in December 2015 though a Plan of Arrangement valued at approximately $30 million. Peter was educated at Cambridge University and the University of British Columbia.

Veritas Pharma CEO, Dr. Lui Franciosi commented, “the variety of cannabis that Whistler has to offer will ensure that Cannevert will have the best quality and quantity of material needed to conduct research. As well, having Whistler’s co-founder, Jesse McConnell advising us on the best genetics to examine, based existing patient feedback, will help us streamline our focus.  We are also excited to have Peter Doig and Peter Smith to provide guidance on the strategic growth of our company in this industry.”

About VERITAS Pharma Inc.

Veritas Pharma Inc. is an early stage pharmaceutical company developing innovative medicinal cannabis cultivars for specific disease conditions such as chronic pain, emesis (nausea/vomiting), and epilepsy. Using a ‘lean and mean’ approach to product development, the company aims to select candidate cultivars using classical pharmacology techniques and then immediately evaluate them in the clinic to maximize both product value and shareholder return. Veritas’s scientists are an inter-disciplinary team that consists of chemists, pharmacologists, anesthetists, and clinical pharmacologists. Their focus is to use their knowledge to streamline the development of cannabis based treatments to capture considerable market share. Also through its wholly owned subsidiary, Sechelt Organic Marijuana Corp., has applied to Health Canada for a medical marijuana production and distribution license under the Marihuana for Medical Purposes Regulations (the “MMPR“).

On behalf of the Board of Directors Veritas Pharma Inc.
“Dr. Lui Franciosi”
Dr. Lui Franciosi
Chief Executive Officer

Further information about the Company is available on our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com and on the CSE website at www.thecse.com.

Investor and Public Relations Contact

Veritas Pharma Inc.
Dr. Lui Franciosi
Chief Executive Officer
Telephone: +1.778.968.6260
Email: [email protected]

The CSE has not reviewed, nor approved or disapproved the content of this press release.

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!